Mayo Clinic: Esophageal Neoplasms trials
The registry lists 12 Esophageal Neoplasms studies with Mayo Clinic as lead sponsor. 3 are open to participants now and 1 have results posted.
Phase 1 1Phase 2 2No phase 9(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Immune Checkpoint Inhibitor Response in Solid Tumors Using a Live Tumor Diagnostic PlatformRecruitingNCT06349642
- Comparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access and Remote Expertise) Beyond Walls (CCBW) ProgramRecruitingNCT06265285Phase 2
- Mayo Clinic Upper Digestive Disease SurveyRecruitingNCT02530983
- Doxepin Hydrochloride in Treating Esophageal Pain in Patients With Thoracic Cancer Receiving Radiation Therapy to the Thorax With or Without ChemotherapyTerminatedNCT02062632Phase 2Results posted
- Defining Musical Toxicity and Its Effect on Patient Well-beingWithdrawnNCT06494046
- Nitrates and IL-8 in Barrett's EsophagusTerminatedNCT04642690
- Minimally Invasive Molecular Approaches for the Diagnosis of Barrett's Esophagus and Esophageal AdenocarcinomaCompletedNCT03961945Not applicable
- Measuring Cell Free DNA During the Course of Treatment for Esophageal Cancer as a Marker of Response and RecurrenceTerminatedNCT03108885
- Study of Inspiratory Muscle Training for Patients Undergoing Esophageal SurgeryWithdrawnNCT02843750Not applicable
- Pencil Beam Scanning Proton Radiotherapy for Esophageal CancerCompletedNCT02452021
- Quality of Life in Patients Undergoing Radiation Therapy for Primary Lung Cancer, Head and Neck Cancer, or Gastrointestinal CancerCompletedNCT00836992
- Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Gastrointestinal CancerCompletedNCT00654160Phase 1